Viewing Study NCT06426862



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06426862
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2024-05-19

Brief Title: Effects of Otago Exercise Program in Falls Balance and Physical Performance in Stroke Patients
Sponsor: Riphah International University
Organization: Riphah International University

Study Overview

Official Title: To Determine the Effects of the Otago Exercise Program on the Frequency of Falls Balance Capabilities and Overall Physical Performance in Stroke Patients
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to determine the effects of the Otago Exercise Program OEP on falls and balance as well as overall physical performance Participants will be divided into two groups control and intervention group It is a week-long study the participants will be assessed through the Berg Balance Scale BBS Time Up and Go TUG and Fugl-Meyer Assessment FMA
Detailed Description: The previous literature suggested that the Otago exercise showed significant improvement in terms of fall and balance Most of the Studies were conducted on the elderly population but limited studies are available regarding stroke This study will look at the effect of Otago exercise on stroke patients The Otago exercise consists of 17 exercises strengthening and balancing exercises The participants will receive Otago exercise and routine physiotherapy treatment for six weeks The participants will go through three assessments Baseline Assessment After 3 weeks assessment and final assessment For association a mixed method ANOVA test will be used

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None